An American doll brings to life by a static frequency from an alam clock. Enjoying her temporary life, she gives out all his strength to show everybody what she got on stage. Fascinated by the clip? Want to see some more of these? Check out this link ==> www.adasport.com and vote for this clip. Voting is officially open!
An early crop of advanced crash avoidance technologies includes some clear success stories when it comes to preventing crashes, insurance claim analyses by the Highway Loss Data Institute (HLDI) show.
Forward collision avoidance systems, particularly those that can brake autonomously, along with adaptive headlights, which shift direction as the driver steers, show the biggest crash reductions. Lane departure warning appears to hurt, rather than help, though it’s not clear why, and other systems, such as blind spot detection and park assist, aren’t showing clear effects on crash patterns yet.
HLDI analysts looked at how each feature affected claim frequency under a variety of insurance coverages for damage and injuries. Clear patterns were seen in claims under property damage liability (PDL) insurance, which covers damage caused by the insured vehicle to another vehicle, and collision insurance, which covers damage to the insured vehicle. Frequency is measured as the number of claims relative to the number of insured vehicle years. An insured vehicle year is one vehicle insured for one year, two vehicles for six months, etc. The model years of the vehicles included ranged from 2000 to 2011, depending on when an automaker introduced a feature. Insurance data through August 2011 were used.
Just in time for the busiest travel season of the year, State Farm has released its annual research report on distracted driving, with troubling results. Though texting while driving remains a concern on the nation’s highways, people are also webbing while driving with increasing frequency. These behaviors may pose equal or greater concerns in the effort to reduce distracted driving.
The July 2012 survey of nearly 1000 motorists shines a light on a growing safety concern: people accessing the internet while driving. Four years of data show a significant increase in the use of mobile web services while driving.
To view Multimedia News Release, go to http://www.multivu.com/mnr/56793-state-farm-fourth-annual-survey-shows-significant-use-mobile-web-vehicle
Based on its recent analysis of the radio frequency (RF) and electromagnetic compatibility (EMC) measurement technologies market, Frost & Sullivan recognizes EMSCAN with the 2010 Global Frost & Sullivan Award for Customer Value Enhancement of the Year.
EMSCAN’s innovative electromagnetic (EM) measurement technologies offer faster alternatives to existing solutions for pre-compliance antenna measurement and EM testing, more specifically for small size antennas that operate in the 300 megahertz (MHz) to 6 gigahertz (GHz) frequency range and printed circuit boards (PCBs) that radiate in the 50 kilohertz (kHz) to 4 GHz range. Both its products, the EMxpert and the RFxpert, use high-speed automatically switched high-density planar antenna array patented by EMSCAN.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/emscan/50432/
A special double treat awaits China and Asia-bound travelers from New York on March 31, 2013 when Air China, China’s exclusive national flag carrier, upgrades its aircraft to the state-of-the-art Boeing 777-300ER and increase its frequency from 7 to 11 per week for its nonstop New York-Beijing flights.
“Adding new flights is a response to a consistently growing passenger demand for more convenient nonstop services between New York and Beijing. Business or leisure travelers bound for Beijing or onward to domestic Chinese cities and other destinations in Asia such as Hong Kong, Vietnam, India, the Philippines, Thailand and many others, stand to benefit the most from Air China’s increased capacity and convenient connecting flights,” Mr. Yuelong Zhou, Air China’s General Manager in New York, said.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60071-air-china-beijing-new-york-service-upgrade-to-boeing-777-300er
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
